Synthetic peptide vaccines effective in preventing virus infection

Microbiology and Immunology

Volumn 43, Issue 10, 1999, Pages 915-923

  Ogasawara, Kazumasa ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

CD40 CD40L; Cytotoxic T cell; Dendritic cell; Helper T cell; Peptide vaccine

Indexed keywords

CD40 ANTIGEN; NEUTRALIZING ANTIBODY; PEPTIDE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VIRUS INFECTION;

ANIMALIA;

EID: 0032704006     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb03352.x     Document Type: Short Survey

References (69)

1. Albert, M.L., Sauter, B., and Bhardwaj, N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.
2. Alexander, J., Sidney, J., Southwood, S., Ruppert, J.C., Oseroff, C., Maewal, A., Snoke, K., Serra, H.M., Kubo, R.T., Sette, A., and Grey, H.M. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1: 751-761.
3. Austyn, J.M. 1996. New insights into the mobilization and phagocytotic activity of dendritic cells. J. Exp. Med. 183: 1287-1292.
4. Bancherau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
5. Bennett, S.R., Carbone, F.R., Karamalis, F., Flavell, R.A., Miller, J.F., and Heath, W.R. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478-480.
6. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., and Wiley, D.C. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512.
7. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33-39.
8. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., and Falo, L.D., Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183: 283-287.
9. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H.G., and Townsend, A. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 21: 2069-2075.
10. Chicz, R.M., Urban, R.G., Gorga, J.C., Vignali, D.A., Lane, W.S., and Strominger, J.L. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178: 27-47.
11. Chien, Y., Becker, D.M., Lindsten, T., Okamura, M., Cohen, D.I., and Davis, M.M. 1984. A third type of murine T-cell receptor gene. Nature 312: 31-35.
12. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., and Mathis, D. 1991. Mice lacking MHC class II molecules. Cell 66: 1051-1066.
13. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.G. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
14. b. Science 257: 919-927.
15. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001-1004.
16. k in complex with a dominant epitope of lysozyme. Immunity 8: 305-317.
17. Garboczi, D., Ghosh, P., Utz, U., Fan, Q., Biddison, W., and Wiley, D. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-141.
18. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. 1996. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274: 209-219.
19. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D. C. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378: 457-462.
20. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74: 197-203.
21. Hedrick, S.M., Cohen, D.I., Nielsen, E.A., and Davis, M.M. 1984. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308: 149-153.
22. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. 1991. HLA 1991, p. 1065-1220. In Tsuji, K., Aizawa, M., and Sasazuki, T. (eds), Oxford University Press, New York.
23. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K.S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P.S., Ikehara, S., Muramatsu, S., Hodes, R.J., and Steinman, R.M. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180: 1849-1860.
24. + T cells. J. Exp. Med. 185: 2133-2141.
25. b molecules. Eur. J. Immunol. 26: 1314-1321.
26. b molecule. Proc. Natl. Acad. Sci. U.S.A. 94: 12047-12052.
27. Kappler, J.K., Roehm, N., and Marrack, P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280.
28. Kida, H., Kawaoka, Y., Naeve, C.W., and Webster, R.G. 1987. Antigenic and genetic conservation of H3 influenza virus in wild ducks. Virology 159: 109-119.
29. Kida, H., Shortridge, K.F., and Webster, R.G. 1988. Origin of the hemagglutinin gene of H3N2 influenza viruses from pigs in China. Virology 162: 160-166.
30. + thymocytes. Nature 333: 742-746.
31. Kovacsovics-Bankowski, M., and Rock, K.L. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243-246.
32. Krumel, M.F., and Allison, J.P. 1995. CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182: 459-465.
33. Leach, D.R., Krummel, M.F., and Allison, J.P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271: 1734-1736.
34. Madden, D.R., Gorga, J.C., Strominger, J.L., and Wiley, D.C. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353: 321-325.
35. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. 1994. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369: 67-71.
36. Matsuki, N., Ogasawara, K., Takami, K., Namba, K., Takahashi, A., Fukui, Y., Sasazuki, T., Iwabuchi, K., Good, R.A., and Onoé, K. 1999. Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory. Vaccine 17: 1161-1168.
37. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., DeLeo, A.B., and Lotze, M.T. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1: 1297-1302.
38. Naruse, H., Ogasawara, K., Kaneda, R., Hatakeyama, S., Itoh, T., Kida, H., Miyazaki, T., Good, R.A., and Onoé, K. 1994. A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years. Proc. Natl. Acad. Sci. U.S.A. 91: 9588-9592.
39. Norbury, C.C., Hewlett, L.J., Prescott, A.R., Shastri, N., and Watts, C. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3: 783-791.
40. Ogasawara, K., Maloy, W.L., and Schwartz, R.H. 1987. Failure to find holes in the T-cell repertoire. Nature 325: 450-452.
41. Ogasawara, K., Maloy, W.L., Beverly, B., and Schwartz, R.H. 1989. Functional analysis of the antigenic structure of a minor T cell determinant from pigeon cytochrome c: evidence against an α-helical conformation. J. Immunol. 142: 1448-1456.
42. Ogasawara, K., Naruse, H., Itoh, Y., Gotohda, T., Arikawa, J., Kida, H., Good, R.A., and Onoé, K. 1992. A strategy for making synthetic peptide vaccines. Proc. Natl. Acad. Sci. U.S.A. 89: 8995-8999.
43. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J., and Harding, C.V. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361: 359-362.
44. Porgador, A., and Gilboa, E. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182: 255-260.
45. Racioppi, L., Ronchese, F., Matis, L.A., and Germain, R.N. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177: 1047-1060.
46. Rammensee, H.G., Friede, T., and Stevanović, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
47. + T-helper and a T-killer cell. Nature 393: 474-478.
48. Rudensky, A.Y., Preston-Hurlburt, P., Al-Ramadi, B.K., Rothbard, J., and Janeway, C.A., Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359: 429-431.
49. Saper, M.A., Bjorkman, P.L., and Wiley, D.C. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219: 277-319.
50. Schaeffer, E.L., Sette, A., 0Johnson, D.L., Bekoff, M.C., Smith, J.M., Grey, H.M., and Buus, S. 1989. Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. Proc. Natl. Acad. Sci. U.S.A. 86: 4649-4653.
51. Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R., and Melief, C.J.M. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
52. Schumacher, T.N., De Bruijn, M.L., Vernie, L.N., Kast, W.M., Melief, C.J., Neefjes, J.J., and Ploegh, H.L. 1991. Peptide selection by MHC class I molecules. Nature 350: 703-706.
53. Schwartz, R.H. 1985. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3: 237-261.
54. Sha, W.C., Nelson, C.A., Newberry, R., Kranz, D.M., Russell, J.H., and Loh, D.Y. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336: 73-76.
55. Shen, Z., Reznikoff, G., Dranoff, G., and Rock, K.L. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158: 2723-2730.
56. Sigal, L.J., Crotty, S., Andino, R., and Rock, K.L. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80.
57. Sloan-Lancaster, J., Evavold, B.D., and Allen, P.M. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363: 156-159.
58. Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B., and Allen, P.M. 1994. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79: 913-922.
59. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
60. Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu, X., Fukuda, K., and Cox, N. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279: 393-396.
61. Takahashi, A., Ogasawara, K., Matsuki, N., Fujinaga, K., Nakaya, T., Ikuta, K., Auwanit, W., Honda, M., Fukui, Y., Sasazuki, T., Iwabuchi, K., and Onoé, K. 1998. Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice. Vaccine 16: 1537-1543.
62. Uenaka A., Ono, T., Akisawa, T., Wada, H., Yasuda, T., and Nakayama, E. 1994. Identification of a unique antigen peptide pRL1 on BALB/c RL ♂ 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J. Exp. Med. 180: 1599-1607.
63. Unanue, E.R., and Cerottini, J.C. 1989. Antigen presentation. FASEB J. 3: 2496-2502.
64. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.
65. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413.
66. Wiley, D.C., Wilson, I.A., and Skehel, J.J. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
67. Wilson, I.A., Skehel, J.J., and Wiley, D.C. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289: 366-373.
68. Yamamoto, K., Fukui, Y., Esaki, Y., Inamitsu, T., Sudo, T., Yamane, K., Kamikawaji, N., Kimura, A., and Sasazuki, T. 1994. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J. Exp. Med. 180: 165-171.
69. Yanagi, Y., Yoshikai, Y., Leggett, K., Clark, S.P., Aleksander, I., and Mak, T.W. 1984. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature 308: 145-149.